【摘 要】
:
UCN-01 (7-Hydroxystaurosporine) is an investigational anticancer agent that is currently being evaluated as targeted therapy in phase II clinical studies. The a
【机 构】
:
ClinicalPharmacologyResearchCore,DepartmentofPharmacyPracticeandScience,OfficeofClinicalPharmacology